|
The breast cancer death rate in
the United States has dropped significantly, but Black
women continue to be more likely to die from the disease despite having a
lower incidence of it, according to a new American Cancer Society report. The study finds that in total, the death
rate dropped by 43% within three decades, from 1989 to 2020, translating to
460,000 fewer breast cancer deaths during that time. The researchers found that the
incidence of breast cancer has risen slowly since 2004, by about 0.5% per
year, driven mostly by diagnosing the disease early and more quickly at a localized
stage. In contrast, breast cancer
death rates have declined steadily since their peak in 1989, the researchers
found, falling 1.9% annually from 2002 to 2011 and then 1.3% annually from
2011 to 2022. When the data were analyzed by
race, Black women had a lower incidence rate of breast cancer versus White
women, but the death rate was 40% higher in Black women overall. “Death rates are declining in
Black women, just like they are in almost every other group, but we’re still
seeing the same gap,” said Rebecca Siegel, senior scientific director of
surveillance research at the American Cancer Society and senior author of the
report. “The evidence is consistent
that Black women receive short shrift in the health care system at every
point of the breast cancer care continuum, from lower-quality mammography to
delays between the time of diagnosis and the beginning of treatment to poor
quality treatment when they are diagnosed,” Siegel said. “The take-home
message is that we really need to take a hard look at how we’re treating
Black women differently.” |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
No comments:
Post a Comment